Patent · US Active

Ocular formulations of norketotifen

US8969385B2 · kind B2 · utility

3Cited by

1References

14Claims

0Family size

Assignee

Bridge Pharma, Inc. · US

Inventors

A. K. Gunnar Aberg · Sarasota, US
Keith Johnson · Durham, US

Key dates

Filing date	Apr 15, 2014
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Apr 15, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Ophthalmic compositions containing norketotifen and methods of making the same and the use thereof are disclosed. The methods also comprise administering to the eyes of a mammal in need thereof topical ophthalmic compositions containing norketotifen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.